Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The human genome project has yielded many discoveries about complex human characteristics, but using this information to identify new drugs has largely eluded scientists. Now, researchers have described compounds related to human memory, one of which produced a drug-induced reduction in negative memories.
The researchers, from the University of Basel in Switzerland, believe their findings could aid in the treatment of post-traumatic stress disorder (PTSD). They describe their results in a study published in the journal PNAS.
According to the National Institute of Mental Health, PTSD affects around 7.7 million American adults, but children can also suffer from the condition.
The organization says that PTSD symptoms can be grouped into three categories:
The researchers, including Prof. Andreas Papassotiropoulos from the Department of Psychology at the University of Basel, conducted a multinational collaborative study to assess the genetic underpinnings of emotionally aversive memory, which is linked to PTSD.
The team was able to identify 20 potential drug target genes in two gene sets:
In their study, which was double-blind and placebo-controlled, they observed a compound that interacts with one of the gene products.
Interestingly, the compound involved in the interaction was a popular antihistamine, and just a single dose of it resulted in a major reduction of recalling negative memories - in this case, aversive pictures the participants had previously seen.
Additionally, the antihistamine did not affect the memories of neutral or positive pictures.
The authors note that for the first time, these results "demonstrate that genome information, along with appropriate data mining methodology, can be used as a starting point for the identification of memory-modulating compounds," and the findings could also have implications for treating PTSD.
Prof. Papassotiropoulos adds:
"The rapid development of innovative methods for genetic analysis has made this new and promising approach possible."
The researchers say they are planning further studies, during which they will attempt to identify and create memory-enhancing drugs.
Medical News Today recently reported that scientists successfully disrupted unwanted memories in mice while leaving the rest untouched.
Written by Marie Ellis
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Human genome–guided identiﬁcation of memory-modulating drugs, Andreas Papassotiropoulos, et al., PNAS, doi: 10.1073/pnas.1314478110, published online 21 October 2013.
University of Basel Release, accessed 22 October 2013.
Visit our Genetics category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Ellis, Marie. "Antihistamine compound reduces bad memories." Medical News Today. MediLexicon, Intl., 22 Oct. 2013. Web.
8 Dec. 2013. <http://www.medicalnewstoday.com/articles/267762>
Ellis, M. (2013, October 22). "Antihistamine compound reduces bad memories." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/267762.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.